James McCullough | executive |
Thomas McLain | executive |
Oliver Sterling | executive |
Daniel Arias | analyst |
Mark Massaro | analyst |
Randy Baron | analyst |
Good morning, and welcome to the Renalytix conference call to review third quarter fiscal year 2023 Financial Results. [Operator Instructions] And as a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Peter DeNardo of CapComm Partners for a few introductory comments. Sir, please go ahead.
Thank you, Chris.